×
验证码:
换一张
Forgotten Password?
Stay signed in
Login With UMPASS
English
|
繁體
Login With UMPASS
Log In
ALL
ORCID
TI
AU
PY
SU
KW
TY
JN
DA
IN
PB
FP
ST
SM
Study Hall
Image search
Paste the image URL
Home
Faculties & Institutes
Scholars
Publications
Subjects
Statistics
News
Search in the results
Faculties & Institutes
Institute of Chi... [3]
THE STATE KEY LA... [2]
Authors
ZHANG QINGWEN [1]
Document Type
Journal article [3]
Date Issued
2024 [1]
2020 [1]
2017 [1]
Language
英語English [3]
Source Publication
JOURNAL OF MEDIC... [1]
Journal of Nanob... [1]
Medicine [1]
Indexed By
SCIE [3]
IC [1]
Funding Organization
Funding Project
×
Knowledge Map
UM
Start a Submission
Submissions
Unclaimed
Claimed
Attach Fulltext
Bookmarks
Browse/Search Results:
1-3 of 3
Help
Selected(
0
)
Clear
Items/Page:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
Sort:
Select
Issue Date Ascending
Issue Date Descending
Journal Impact Factor Ascending
Journal Impact Factor Descending
WOS Cited Times Ascending
WOS Cited Times Descending
Submit date Ascending
Submit date Descending
Title Ascending
Title Descending
Author Ascending
Author Descending
Enzyme/ROS dual-sensitive nanoplatform with on-demand Celastrol release capacity for enhanced ulcerative colitis therapy by ROS scavenging, microbiota rebalancing, inflammation alleviating
Journal article
Shi, Jinfeng, Zhou, Jiahui, Liu, Bo, Lin, Kezhou, Xie, Xingliang, Han, Xue, Sheng, Yanmei, Liu, Yihan, He, Congjian, Zhou, Yujin, Zhu, Nan, Yang, Qian, Luo, Ruifeng, Li, Yi. Enzyme/ROS dual-sensitive nanoplatform with on-demand Celastrol release capacity for enhanced ulcerative colitis therapy by ROS scavenging, microbiota rebalancing, inflammation alleviating[J]. Journal of Nanobiotechnology, 2024, 22(1), 437.
Authors:
Shi, Jinfeng
;
Zhou, Jiahui
;
Liu, Bo
;
Lin, Kezhou
;
Xie, Xingliang
; et al.
Favorite
|
TC[WOS]:
2
TC[Scopus]:
2
IF:
10.6
/
11.4
|
Submit date:2024/08/05
Celastrol
Enzyme/ros-triggered Controlled Release
Ros Scavengers
Ulcerative Colitis
Therapeutic efficacy and safety of Kangfuxin in combination with rabeprazole in the treatment of peptic ulcer: A systematic review and meta-analysis
Journal article
Lin, Meisi, Zhang, Siyuan, Zhang, Minyue, Shi, Jinfeng, Zhang, Chen, Luo, Ruifeng, You, Jieshu, Sun, Jiayi, Zhang, Jinming, Gao, Fei. Therapeutic efficacy and safety of Kangfuxin in combination with rabeprazole in the treatment of peptic ulcer: A systematic review and meta-analysis[J]. Medicine, 2020, 99(48), e23103.
Authors:
Lin, Meisi
;
Zhang, Siyuan
;
Zhang, Minyue
;
Shi, Jinfeng
;
Zhang, Chen
; et al.
Favorite
|
TC[WOS]:
3
TC[Scopus]:
1
IF:
1.3
/
1.6
|
Submit date:2021/12/06
Peptic Ulcer
Kangfuxin
Rabeprazole
Meta-analysis
Combination
Periplaneta Americana
Structure Based Design of N-(3-((1H-Pyrazolo[3,4-b]pyridin-5-yl)ethynyl)benzenesulfonamides as Selective Leucine-Zipper and Sterile-alpha Motif Kinase (ZAK) Inhibitors
Journal article
Chang, Yu, Lu, Xiaoyun, Shibu, Marthandam Asokan, Dai, Yi-Bo, Luo, Jinfeng, Zhang, Yan, Li, Yingjun, Zhao, Peng, Zhang, Zhang, Xu, Yong, Tu, Zheng-Chao, Zhang, Qing-Wen, Yun, Cai-Hong, Huang, Chih-Yang, Ding, Ke. Structure Based Design of N-(3-((1H-Pyrazolo[3,4-b]pyridin-5-yl)ethynyl)benzenesulfonamides as Selective Leucine-Zipper and Sterile-alpha Motif Kinase (ZAK) Inhibitors[J]. JOURNAL OF MEDICINAL CHEMISTRY, 2017, 60(13), 5927-5932.
Authors:
Chang, Yu
;
Lu, Xiaoyun
;
Shibu, Marthandam Asokan
;
Dai, Yi-Bo
;
Luo, Jinfeng
; et al.
Favorite
|
TC[WOS]:
21
TC[Scopus]:
20
IF:
6.8
/
7.1
|
Submit date:2018/10/30